Endometrium with changes due to selective progesterone receptor modulators
Revision as of 23:24, 1 January 2018 by Michael (talk | contribs) (Michael moved page Selective progesterone receptor modulators to Endometrium with changes due to selective progesterone receptor modulator: make it about the endometrium)
Selective progesterone receptor modulators, abbreviated SPRMs, are a class of drugs that block the action of progesterone. They are used to treat uterine fibroids.[1]
General
- Ulipristal - trade name Fibristal.
- May be used as an emergency contraceptive.[2]
Microscopic
Features:[1]
- Glandular changes - extensive cystic dilatation.
- Inactive appearing glandular epithelium or abortive subnuclear vacuolization.
- Rare mitoses and apoptosis.
- Abnormal stromal vessels - common.
DDx:
See also
References
- ↑ 1.0 1.1 Williams, AR.; Bergeron, C.; Barlow, DH.; Ferenczy, A. (Nov 2012). "Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.". Int J Gynecol Pathol 31 (6): 556-69. doi:10.1097/PGP.0b013e318251035b. PMID 23018219.
- ↑ Whitaker, LH.; Williams, AR.; Critchley, HO. (Aug 2014). "Selective progesterone receptor modulators.". Curr Opin Obstet Gynecol 26 (4): 237-42. doi:10.1097/GCO.0000000000000082. PMID 24950125.